Thrombolytic therapy: Agents, Indications, and Laboratory Monitoring
Open Access
- 1 May 1994
- journal article
- review article
- Published by Elsevier in Medical Clinics of North America
- Vol. 78 (3) , 745-764
- https://doi.org/10.1016/s0025-7125(16)30156-0
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Thrombolytic Agents in Acute Myocardial InfarctionNew England Journal of Medicine, 1989
- Effect of Intravenous Streptokinase as Compared with That of Tissue Plasminogen Activator on Left Ventricular Function after First Myocardial InfarctionNew England Journal of Medicine, 1989
- A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary AngioplastyNew England Journal of Medicine, 1987
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial InfarctionNew England Journal of Medicine, 1984
- Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris.Circulation, 1981
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980
- Pulmonary embolectomy, heparin, and streptokinase: Their place in the treatment of acute massive pulmonary embolismAmerican Heart Journal, 1977
- Declotting of Quinton-Scribner shuntsAmerican Heart Journal, 1971